About Translational Research
Cancer is a killing disease, which occurs in any age groups. Clinicians and scientists around the world have been carrying out researches days and nights, hoping to discover new treatment strategies which fight against cancer and relieve patients’ pain.
Cancer is not a single disease. It is a family of diseases with similar origin, progression and treatment strategy. Cancer is caused by abnormal rapid growth of cells. These cells divide and multiply unchecked, often becoming tumors that invade healthy tissue. They also quickly adapt to changes in their environment and are capable of developing resistance to accepted treatment regimens.
Cancer cells are very dangerous. Conventional treatment is tumour resection followed by heavy dosage chemotherapy, which brings many side effects. ‘Translational research’ is the latest method in cancer research in recent years. Translational treatment simply links the laboratory research results and clinical trials, thus creating treatments for different patients. In this way, side effects are lessened and efficiency is not compromised.
In Translational Research, advances in molecular genetics, regulatory proteins, cellular signalling and other relevant areas can be applied to new diagnostic technologies, targeted treatments and prevention strategies to help the cancer patient. Physician-scientists play a crucial role in the continuum of research that ensures a free flow of information and new treatments from the laboratory to the patient bedside and back again.